Graduate School of Life Science and Faculty of Advanced Life Science, Hokkaido University, N21, W11, kita-ku, Sapporo, 001-0021, Japan.
Angew Chem Int Ed Engl. 2019 Oct 7;58(41):14513-14518. doi: 10.1002/anie.201907778. Epub 2019 Aug 30.
Activated endocytosis of extracellular macromolecules and their intracellular trafficking to lysosomes is an essential metabolic mechanism in cancer cells during their rapid proliferation. Cancer cells reuse a vast amount of N-acetylglucosamine (GlcNAc) supplied from the GlcNAc salvage pathway for the accelerated synthesis of a pivotal uridine diphosphate (UDP)-GlcNAc. A method to inactivate key glycosidases in lysosomes could critically contribute to the development of potent anticancer therapy. Here we demonstrate that "nanosomes" made of core metals covered by an antiadhesive mixed self-assembled monolayer allow for avoiding nonspecific surface protein corona and targeted molecular delivery through activated endocytosis. Nanosomes carrying suicide substrates showed that lysosomal glycosidases such as β-hexosaminidase and β-galactosidase in cancer cells are promising targets for novel anticancer therapeutic nanomedicine that induce apoptotic cell death through lysosomal membrane permeabilization. The advantage of this method is evident because multivalent surface loading by antiadhesive nanosomes makes it possible to highlight "weak interactions" such as carbohydrate-lectin interactions independent of surface protein corona.
细胞外大分子的激活内吞及其向溶酶体的细胞内运输是癌细胞在快速增殖过程中的一种重要代谢机制。癌细胞从 GlcNAc salvage 途径中重新利用大量的 N-乙酰葡萄糖胺(GlcNAc),用于加速合成关键的尿苷二磷酸(UDP)-GlcNAc。抑制溶酶体中关键糖苷酶的方法可能会极大地促进有效的抗癌治疗的发展。在这里,我们证明了由覆盖有抗粘连混合自组装单层的核心金属制成的“纳米体”可以避免非特异性表面蛋白冠,并通过激活内吞作用进行靶向分子传递。携带自杀底物的纳米体表明,癌细胞中的溶酶体糖苷酶,如β-己糖胺酶和β-半乳糖苷酶,是通过溶酶体膜通透性诱导细胞凋亡死亡的新型抗癌治疗纳米医学的有前途的靶点。这种方法的优势是显而易见的,因为抗粘连纳米体的多价表面负载使得有可能突出“弱相互作用”,如碳水化合物-凝集素相互作用,而不依赖于表面蛋白冠。